Long-Term Results of Surgical Ventricular Reconstruction in Ischemic Cardiomyopathy
Researchers compared long-term outcomes following surgical ventricular reconstruction (SVR) between the STICH trial and a high-volume SVR institution.
Researchers compared long-term outcomes following surgical ventricular reconstruction (SVR) between the STICH trial and a high-volume SVR institution.
Investigators sought to evaluate the ability of LGE cardiovascular magnetic resonance to identify myocardial scar and etiology.
Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin.
The Italian Society of Cardiology and Italian Society of Paediatric Cardiology have published a position paper on diagnosis and management of rare cardiomyopathies.
Investigators compared the prognostic value of the N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in DCM and MDCM.
For patients with obstructive hypertrophic cardiomyopathy (HCM), mavacamten improves symptoms and reduces the need for septal reduction therapy (SRT).
Investigators examined differences in demographic and clinical characteristics, treatments, and outcomes for patient with obstructive hypertrophic cardiomyopathy.
Patients with Takotsubo cardiomyopathy (TCM), which is typically due to a neurocardiogenic mechanism, with migraine have lower odds of mortality and acute complications compared with TCM patients without migraine.
A look into the growing number of cases of stress cardiomyopathy, also known as Takotsubo syndrome, that have been observed during the COVID-19 pandemic.
A cross-sectional study was conducted to determine the prevalence of familial idiopathic dilated cardiomyopathy and its age-specific cumulative risk in first-degree relatives.